Featured Insights and Perspectives from Darwin

The latest insights, ideas, and perspectives from Darwin, updated weekly. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Our Take Newsletter

Darwin's Our Take: Botox, Trulicity, Xolair among drugs selected for next round of Medicare price negotiations

Read Now

News and Insights

Showing items 1 to3 of 6

Categories
Tags
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Results 1

Date
Darwin's Our Take: Botox, Trulicity, Xolair among drugs selected for next round of Medicare price negotiations
Insight
Our Take Newsletter
February 2, 2026

Darwin's Our Take: Botox, Trulicity, Xolair among drugs selected for next round of Medicare price negotiations

Learn More
February 2, 2026
unitedhealth
gsk
abbvie
Eli Lilly
healthcare
Darwin's Our Take: Health insurance CEOs catch flak at House hearings on affordability, blame others for high costs
Insight
Our Take Newsletter
January 25, 2026

Darwin's Our Take: Health insurance CEOs catch flak at House hearings on affordability, blame others for high costs

Learn More
January 25, 2026
ourtake
health
healthcare
Darwin's Our Take: Anthropic, OpenAI unveil new AI tools for health care enterprises
Insight
Our Take Newsletter
January 18, 2026

Darwin's Our Take: Anthropic, OpenAI unveil new AI tools for health care enterprises

Learn More
January 18, 2026
ourtake
AI
healthcare
health
healthcare technology
Darwin's Our Take: OpenAI introduces ChatGPT Health to further integrate users' health information
Insight
Our Take Newsletter
January 11, 2026

Darwin's Our Take: OpenAI introduces ChatGPT Health to further integrate users' health information

Learn More
January 11, 2026
Eli Lilly
health
healthcare technology
AI
Darwin's Our Take: FDA approves Novo Nordisk’s Wegovy pill
Insight
Our Take Newsletter
January 5, 2026

Darwin's Our Take: FDA approves Novo Nordisk’s Wegovy pill

Learn More
January 5, 2026
health
fda
Novo Nordisk
Darwin's Our Take: Another 9 drugmakers agree to most-favored-nation pricing on certain products
Insight
Our Take Newsletter
December 22, 2025

Darwin's Our Take: Another 9 drugmakers agree to most-favored-nation pricing on certain products

Learn More
December 22, 2025
drugmaker
drug
american medical association
Darwin's Our Take: Lilly’s ‘triple G’ candidate exceeds analysts’ expectations
Insight
Our Take Newsletter
January 14, 2026

Darwin's Our Take: Lilly’s ‘triple G’ candidate exceeds analysts’ expectations

Learn More
January 14, 2026
ourtake
retatrutide
Our Take: Eli Lilly achieves market value of $1 trillion
Insight
Our Take Newsletter
December 8, 2025

Our Take: Eli Lilly achieves market value of $1 trillion

Learn More
December 8, 2025
Eli Lilly
Novo Nordisk
Our Take: Abbott to boost its diagnostics portfolio with $21 billion acquisition of Exact Sciences
Insight
Our Take Newsletter
November 24, 2025

Our Take: Abbott to boost its diagnostics portfolio with $21 billion acquisition of Exact Sciences

Learn More
November 24, 2025
Cigna
2025
ourtake
abbott
Our Take: CMS launches payment model to lower Medicaid drug spending
Insight
Our Take Newsletter
November 17, 2025

Our Take: CMS launches payment model to lower Medicaid drug spending

Learn More
November 17, 2025
UnitedHealthcare
CMS
medicaid
drug
2025
Our Take: Pfizer wins bidding war to acquire Metsera
Insight
Our Take Newsletter
November 10, 2025

Our Take: Pfizer wins bidding war to acquire Metsera

Learn More
November 10, 2025
Pfizer
2025
ourtake
Our Take: PBM Express Scripts to ditch rebates, Centene and CVS Health take huge write-downs
Insight
Our Take Newsletter
November 3, 2025

Our Take: PBM Express Scripts to ditch rebates, Centene and CVS Health take huge write-downs

Learn More
November 3, 2025
PBM
2025
ourtake
prescription
CVS
Stay Aware. Stay Informed.

Want to stay ahead of health care trends?

Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.